BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 9704689)

  • 1. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
    J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction > 40% after acute myocardial infarction.
    Johnson DB; Foster RE; Barilla F; Blackwell GG; Roney M; Stanley AW; Kirk K; Orr RA; van der Geest RJ; Reiber JH; Dell'Italia LJ
    J Am Coll Cardiol; 1997 Jan; 29(1):49-54. PubMed ID: 8996294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
    Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
    Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
    Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
    Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C;
    Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling.
    Chang SA; Chang HJ; Choi SI; Chun EJ; Yoon YE; Kim HK; Kim YJ; Choi DJ; Sohn DW; Helm RH; Lardo AC
    Am J Cardiol; 2009 Jul; 104(1):19-23. PubMed ID: 19576315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
    Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
    J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfarction left-ventricular aneurysm: regional stress, function, and remodeling after aneurysmectomy.
    Taniguchi K; Sakurai M; Takahashi T; Imagawa H; Mitsuno M; Nakano S; Kawashima Y; Matsuda H
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):253-9. PubMed ID: 9885114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction.
    Orn S; Manhenke C; Anand IS; Squire I; Nagel E; Edvardsen T; Dickstein K
    Am J Cardiol; 2007 Apr; 99(8):1109-14. PubMed ID: 17437737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
    Tarasov NI; Kokov AN; Barbarash LS
    Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study.
    Nikitin NP; Loh PH; de Silva R; Witte KK; Lukaschuk EI; Parker A; Farnsworth TA; Alamgir FM; Clark AL; Cleland JG
    Int J Cardiol; 2006 Mar; 108(1):76-83. PubMed ID: 16516701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
    Cowan BR; Young AA; Anderson C; Doughty RN; Krittayaphong R; Lonn E; Marwick TH; Reid CM; Sanderson JE; Schmieder RE; Teo K; Wadham AK; Worthley SG; Yu CM; Yusuf S; Jennings GL;
    Am J Cardiol; 2009 Dec; 104(11):1484-9. PubMed ID: 19932779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.